Your browser doesn't support javascript.
loading
Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies.
Borte, M; Kriván, G; Derfalvi, B; Maródi, L; Harrer, T; Jolles, S; Bourgeois, C; Engl, W; Leibl, H; McCoy, B; Gelmont, D; Yel, L.
Afiliação
  • Borte M; Klinikum St Georg GmbH, Klinik für Kinder- und Jugendmedizin, Leipzig, Germany.
  • Kriván G; United St Istvan and St Laszlo Hospital, Budapest, Hungary.
  • Derfalvi B; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Maródi L; Dalhousie University, IWK Health Centre, Halifax, Canada.
  • Harrer T; Department of Infectious and Pediatric Immunology, University of Debrecen, Debrecen, Hungary.
  • Jolles S; Department of Internal Medicine 3, Universitätsklinikum Erlangen, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen-Nürnberg, Germany.
  • Bourgeois C; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
  • Engl W; Baxalta Innovations GmbH, now part of Shire, Vienna, Austria.
  • Leibl H; Baxalta Innovations GmbH, now part of Shire, Vienna, Austria.
  • McCoy B; Baxalta Innovations GmbH, now part of Shire, Vienna, Austria.
  • Gelmont D; Baxalta US Inc., now part of Shire, Cambridge, MA, USA.
  • Yel L; Baxalta US Inc., now part of Shire, Westlake Village, CA, USA.
Clin Exp Immunol ; 187(1): 146-159, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27613250

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Síndromes de Imunodeficiência Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Síndromes de Imunodeficiência Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha